Eroxon® Intense
Erectile Dysfunction (ED) - for stronger sensation
Pre-RegistrationSeeking regulatory approvals in USA, EU, UK
Key Facts
Indication
Erectile Dysfunction (ED) - for stronger sensation
Phase
Pre-Registration
Status
Seeking regulatory approvals in USA, EU, UK
Company
About Futura Medical
Futura Medical has successfully transitioned from an R&D entity to a revenue-generating commercial company with the global launch of Eroxon®, its flagship OTC treatment for erectile dysfunction. Its strategy centers on developing clinically proven, topical sexual health products and commercializing them through de-risked partnerships with major consumer healthcare players like Haleon and Cooper. With a lean, semi-virtual structure and a clear pipeline, Futura aims to capitalize on the large, underserved OTC sexual health market driven by demographic trends and growing consumer self-care demand.
View full company profile